1) two way analysis of variance
配伍组方差分析法
2) active ingredient combination in compound formula
复方组分配伍
3) Composition of Prescription
配伍组方
1.
Effect of Modified Taohe Chengqi Decoction and Its Composition of Prescription on Diabetes Mellitus Endothelium Dysfunction;
加味桃核承气汤及其不同配伍组方对糖尿病血管内皮损伤的影响
5) component compatibility
组分配伍
1.
Method:one hundred and twenty cases of unstable angina were randomly divided into the conventional therapy group,component compatibility group,Pieces group and Xuesaitong group 4 groups,each with 30 cases.
目的:探讨活血药有效组分配伍的不稳定性心绞痛血瘀证患者血清白细胞(WBC),C反应蛋白(CRP)、白介素-6(IL-6)和肿瘤坏死因子α(TNF-α)的影响。
2.
Objective: Explore the blood circulation of the drug component compatibility in patients with unstable angina Systems Fas apoptosis factor.
目的:探讨活血化瘀药组分配伍对不稳定型心绞痛患者血清凋亡因子Fas系统的影响。
3.
In the study,90 unstable angina cases were randomly split into stasis conventional treatment,component compatibility,and Xuesaitong treatment,with 30 cases for each treatment.
方法:将90例不稳定性心绞痛血瘀证患者随机分为常规治疗组、组分配伍组和血塞通组3组,每组30例;观察患者治疗前后纤溶酶原激活剂抑制剂(PAI)、纤溶酶原激活剂(t-PA)和反应蛋白(CRP)的变化及PAI、t-PA与CRP、血脂指标的相关性。
补充资料:容量分析法(见化学分析法)
容量分析法(见化学分析法)
容t分析法见化学分析法
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条